| __timestamp | ACADIA Pharmaceuticals Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 1595000 |
| Thursday, January 1, 2015 | 73869000 | 11434000 |
| Friday, January 1, 2016 | 99284000 | 26546000 |
| Sunday, January 1, 2017 | 149189000 | 39778000 |
| Monday, January 1, 2018 | 187163000 | 53418000 |
| Tuesday, January 1, 2019 | 240385000 | 111997000 |
| Wednesday, January 1, 2020 | 319130000 | 139507000 |
| Friday, January 1, 2021 | 239415000 | 195958000 |
| Saturday, January 1, 2022 | 361575000 | 248149000 |
| Sunday, January 1, 2023 | 351619000 | 232366000 |
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals Inc. and ImmunityBio, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, ACADIA Pharmaceuticals Inc. has consistently increased its R&D budget, peaking in 2022 with a 500% increase from its 2014 levels. This upward trend underscores ACADIA's aggressive pursuit of new therapies and treatments. In contrast, ImmunityBio, Inc. has shown a more volatile pattern, with a significant surge in 2019, marking a 7000% increase from 2014, followed by a steady climb to 2023.
These trends highlight the dynamic nature of R&D investments in the biotech sector, reflecting each company's strategic priorities and market positioning.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited